HomeInsightsStock Comparison

Kimia Biosciences Ltd vs Mangalam Drugs And Organics Ltd Stock Comparison

Kimia Biosciences Ltd vs Mangalam Drugs And Organics Ltd Stock Comparison

Last Updated on: Dec 18, 2025

Key Highlights

  • The Latest Trading Price of Kimia Biosciences Ltd is ₹ 30.21 as of 18 Dec 15:30.
  • The P/E Ratio of Kimia Biosciences Ltd is 0 as of March 2024 .The P/E Ratio of Mangalam Drugs and Organics Ltd is 0 as of March 2024.
  • The Market Cap of Kimia Biosciences Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Mangalam Drugs and Organics Ltd is ₹ 146.65 crore as of March 2024.
  • The revenue of Kimia Biosciences Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Mangalam Drugs and Organics Ltd for the Sep '25 is ₹ 49.57 crore as compare to the Jun '25 revenue of ₹ 57.35 crore. This represent the decline of -13.57%.
  • The ebitda of Kimia Biosciences Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Mangalam Drugs and Organics Ltd for the Sep '25 is ₹ -2.81 crore as compare to the Jun '25 ebitda of ₹ -4.48 crore. This represent the decline of -37.28%.
  • The net profit of Kimia Biosciences Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Mangalam Drugs and Organics Ltd changed from ₹ 0.5 crore to ₹ -7.35 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Kimia Biosciences Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Mangalam Drugs and Organics Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Kimia Biosciences Ltd

  • Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal.
  • The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana.
  • The Company is engaged into the business of Pharamaceutical products. The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr.
  • It came out with a public issue in Feb.'95 to part-finance the project.
  • Commercial production commenced in May '95. During the 1998-99, the company has become a sick industrial units. The Hon'ble BIFR vide order dated 27th December, 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and , thereby, turning-out to be an ancillary industrial Undertaking.

About Mangalam Drugs and Organics Ltd

  • Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001.
  • The company was promoted by Dhoot family.
  • The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates.
  • The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra.

Kimia Biosciences Ltd News Hub

News

Kimia Biosciences to discuss results

Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 14 Novem...

Read more

12 Nov 2025 10:06

News

Kimia Biosciences to convene AGM

Kimia Biosciences announced that the 32th Annual General Meeting(AGM) of the company will ...

Read more

03 Sep 2025 09:50

News

Kimia Biosciences to convene board meeting

Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 29 Augus...

Read more

28 Aug 2025 10:57

News

Kimia Biosciences schedules board meeting

Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 14 Augus...

Read more

11 Aug 2025 10:01

News

Kimia Biosciences EGM scheduled

Kimia Biosciences announced that an Extra Ordinary General Meeting (EGM) of the Company wi...

Read more

26 Jun 2025 17:30

News

Kimia Biosciences to hold board meeting

Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 25 June ...

Read more

21 Jun 2025 17:24

Mangalam Drugs and Organics Ltd News Hub

News

Mangalam Drugs and Organics Ltd leads losers in 'B' group

Billionbrains Garage Ventures Ltd, Physicswallah Ltd, Diffusion Engineers Ltd and Anand Ra...

Read more

19 Nov 2025 14:45

News

Mangalam Drugs and Organics postpones board meeting

Mangalam Drugs and Organics has postponed the meeting of the Board of Directors which was ...

Read more

14 Nov 2025 09:54

News

Mangalam Drugs and Organics to convene board meeting

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

06 Nov 2025 15:55

News

Mangalam Drugs and Organics schedules AGM

Mangalam Drugs and Organics announced that the 52th Annual General Meeting(AGM) of the com...

Read more

08 Sep 2025 15:01

News

Mangalam Drugs and Organics to convene board meeting

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

29 Aug 2025 10:32

News

Mangalam Drugs and Organics to hold board meeting

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

31 Jul 2025 13:50

SWOT Analysis Of Mangalam Drugs and Organics Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Mangalam Drugs and Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Kimia Biosciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Kimia Biosciences Ltd and Mangalam Drugs and Organics Ltd

Which company has a larger market capitalization, Kimia Biosciences Ltd or Mangalam Drugs and Organics Ltd?

Market cap of Kimia Biosciences Ltd is 150 Cr while Market cap of Mangalam Drugs and Organics Ltd is 39 Cr

What are the key factors driving the stock performance of Kimia Biosciences Ltd and Mangalam Drugs and Organics Ltd?

The stock performance of Kimia Biosciences Ltd and Mangalam Drugs and Organics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kimia Biosciences Ltd and Mangalam Drugs and Organics Ltd?

As of December 18, 2025, the Kimia Biosciences Ltd stock price is INR ₹31.84. On the other hand, Mangalam Drugs and Organics Ltd stock price is INR ₹25.14.

How do dividend payouts of Kimia Biosciences Ltd and Mangalam Drugs and Organics Ltd compare?

To compare the dividend payouts of Kimia Biosciences Ltd and Mangalam Drugs and Organics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions